Proving the Business Case for the Internet of Things

Smartphone ovulation test demoed at ACOG

Steve Rogerson
May 2, 2018



Taiwanese mobile health provider iXensor demonstrated its Eveline smart ovulation test at this week’s annual meeting of the American College of Obstetricians & Gynaecologists (ACOG) in Texas. It is said to be the first app-based ovulation test that lets users track and pinpoint their fertility through their smartphones.
 
The company provides the PixoTest technology that turns the front camera of a smartphone into an optical reader and allows seamless digitisation and synchronisation of health information.
 
"The Eveline smart ovulation test is the world's first ovulation tracker that seamlessly integrates the ovulation tests and user's smartphone applications," said Alan Tsai, CEO and co-founder of iXensor. "We aim to make the tracking and guessing work easier and to make all trying-to-conceive women less stressful. I'm proud to say that we did it."
 
The test won the Best of Baby Tech Awards in Fertility and Pregnancy at this year’s CES, recognising its achievements in fertility and pregnancy technology.
 
"Eveline not only brings the ovulation test, but also serves as a platform to provide a total solution for better fertility care," said Claire Tsai, director of business development of iXensor. “The technology can easily adapt with different tests and help manage the women's health through the application. We will continue to extend the technology to provide more products and better care for women.”
 
Founded in 2012, iXensor is a connected device company based in Taipei, Taiwan. Its proprietary PixoTest technology empowers smartphone users to take instant health check-ups on their phones. The patented technology uses the front-facing camera of the smartphone to analyse the colour change of the test strips. With the technology, test strips can be detected directly by the smartphone and apps with seamless synchronisation of test data without any meter or Bluetooth connection.